Data / Form D filings / Theratome Bio, Inc.
Theratome Bio, Inc.: Form D filings
Theratome Bio, Inc., a biotechnology company in Houston, TX, filed 2 Form D notices with the SEC between 2016 and 2023. The latest, on September 21, 2023, reports $28,500 sold of a $950,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9128 Lakes at 610 Drive, Houston, TX, 77054
- Phone
- (832) 452-5117
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1671248
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 21, 2023 | New notice | $950,000 | $28,500 | $921,500 | 1 | Sep 14, 2023 | sec.gov |
| Apr 4, 2016 | New notice | $3,500,000 | $1,890,000 | $1,610,000 | 6 | Feb 3, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael T Redman | Executive Officer, Director | |
| Keith T March MD PhD | Executive Officer, Director | |
| Brad T Miller | Director | |
| James Donald Payne | Executive Officer | |
| Michael Donald Trotta | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Sep 18, 2023 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Theratome Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.